These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33487183)

  • 21. Positive trends in paediatric renal biopsy service provision in the UK: a national survey and re-audit of paediatric renal biopsy practice.
    Gupta A; Campion-Smith J; Hayes W; Deal JE; Gilbert RD; Inward C; Judd BA; Krishnan RG; Marks SD; O'Brien C; Shenoy M; Sinha MD; Tse Y; Tyerman K; Mallik M; Hussain F;
    Pediatr Nephrol; 2016 Apr; 31(4):613-21. PubMed ID: 26525201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Relationship Between Cisplatin-related and Age-related Hearing Loss During an Extended Follow-up.
    Skalleberg J; Småstuen MC; Oldenburg J; Osnes T; Fosså SD; Bunne M
    Laryngoscope; 2020 Sep; 130(9):E515-E521. PubMed ID: 32065408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
    Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions.
    Konrad-Martin D; Poling GL; Garinis AC; Ortiz CE; Hopper J; O'Connell Bennett K; Dille MF
    Int J Audiol; 2018 Sep; 57(sup4):S3-S18. PubMed ID: 29157038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives and practices of ototoxicity monitoring.
    Paken J; Govender CD; Pillay M; Sewram V
    S Afr J Commun Disord; 2020 May; 67(1):e1-e10. PubMed ID: 32501032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.
    Clemens E; van den Heuvel-Eibrink MM; Mulder RL; Kremer LCM; Hudson MM; Skinner R; Constine LS; Bass JK; Kuehni CE; Langer T; van Dalen EC; Bardi E; Bonne NX; Brock PR; Brooks B; Carleton B; Caron E; Chang KW; Johnston K; Knight K; Nathan PC; Orgel E; Prasad PK; Rottenberg J; Scheinemann K; de Vries ACH; Walwyn T; Weiss A; Am Zehnhoff-Dinnesen A; Cohn RJ; Landier W;
    Lancet Oncol; 2019 Jan; 20(1):e29-e41. PubMed ID: 30614474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practice of Monitoring Cisplatin-Induced Ototoxicity by Audiology, ENT, and Oncology Specialists: A Survey-Based Study in a Single Italian Medical Center.
    Gambacorta V; Orzan E; Faralli M; Gullà M; Lapenna R; Baietta I; De Angelis V; Ricci G
    Audiol Res; 2023 Oct; 13(5):779-790. PubMed ID: 37887850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR; Kraemer DF; Winter C; Neuwelt EA
    J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis.
    Al-Malky G; Dawson SJ; Sirimanna T; Bagkeris E; Suri R
    J Cyst Fibros; 2015 Mar; 14(2):248-54. PubMed ID: 25127922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Audiological Monitoring in Children Treated with Platinum Chemotherapy.
    Fetoni AR; Ruggiero A; Lucidi D; De Corso E; Sergi B; Conti G; Paludetti G
    Audiol Neurootol; 2016; 21(4):203-211. PubMed ID: 27286730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ototoxicity-induced hearing loss and quality of life in survivors of paediatric cancer.
    Rajput K; Edwards L; Brock P; Abiodun A; Simpkin P; Al-Malky G
    Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110401. PubMed ID: 33152988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in ototoxicity monitoring in the pediatric oncology population.
    Bass JK; Bhagat SP
    J Am Acad Audiol; 2014 Sep; 25(8):760-74; quiz 782-3. PubMed ID: 25380122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity.
    Paken J; Govender CD; Pillay M; Ayele BT; Sewram V
    BMC Womens Health; 2021 Apr; 21(1):164. PubMed ID: 33879158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Availability of audiological equipment and protocols for paediatric assessment and hearing aid fitting in Gauteng, South Africa.
    Teixeira L; Joubert K
    S Afr J Commun Disord; 2014 Aug; 61(1):. PubMed ID: 26305438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Audiologists' perceived value of ototoxicity management and barriers to implementation for at-risk cancer patients in VA: the OtoMIC survey.
    Konrad-Martin D; Polaski R; DeBacker JR; Theodoroff SM; Garinis A; Lacey C; Johansson K; Mannino R; Milnes T; Hungerford M; Clark KD
    J Cancer Surviv; 2023 Feb; 17(1):69-81. PubMed ID: 36729345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
    Peleva E; Emami N; Alzahrani M; Bezdjian A; Gurberg J; Carret AS; Daniel SJ
    Pediatr Blood Cancer; 2014 Nov; 61(11):2012-7. PubMed ID: 24976616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
    Clemens E; de Vries AC; Pluijm SF; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; van Grotel M; van den Heuvel-Eibrink MM;
    Eur J Cancer; 2016 Dec; 69():77-85. PubMed ID: 27821322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ototoxicity in cancer survivors: experience and proposal of a surveillance protocol].
    Sánchez-Canteli M; Núñez-Batalla F; Martínez-González P; de Lucio-Delgado A; Villegas-Rubio JA; Gómez-Martínez JR; Llorente-Pendás JL
    An Pediatr (Engl Ed); 2020 Sep; ():. PubMed ID: 32998843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contralateral acoustic hearing aid use in adult unilateral cochlear implant recipients: Current provision, practice, and clinical experience in the UK.
    Fielden CA; Kitterick PT
    Cochlear Implants Int; 2016 May; 17(3):132-45. PubMed ID: 27078521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunisation practices of paediatric oncology and shared care oncology consultants: a United Kingdom survey.
    Bate J; Patel SR; Chisholm J; Heath PT;
    Pediatr Blood Cancer; 2010 Jul; 54(7):941-6. PubMed ID: 20162684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.